Skip to main content

Esophageal Cancer: Barrett’s Esophageal Adenocarcinoma (BEA)

  • Chapter
  • First Online:
Endoscopic Treatment Strategy for Upper GI Tract Neoplasms

Abstract

In Japan, there is concern that an increase in Barrett’s esophageal adenocarcinoma (BEA) is caused by decreasing Helicobacter pylori infection rate and Westernization of diet [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: orient to occident. Effects of chronology geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729–35.

    Article  Google Scholar 

  2. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365:1375–83.

    Article  CAS  Google Scholar 

  3. Desai T, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61:970–6.

    Article  Google Scholar 

  4. Matsuhashi N, Sakai E, Ohata K, et al. Surveillance of patients with long-segment Barrett’s esophagus: a multicenter prospective cohort study in Japan. J Gastroenterol Hepatol. 2017;32:409–14. https://doi.org/10.1111/jgh.13491. Epub 2016 Jul 15

    Article  PubMed  Google Scholar 

  5. Rudolph RE, Vaughan TL, Storer BE, et al. Effect of segment length on risk for neoplastic progression in patients with Barret esophagus. Ann Intern Med. 2000;132:612–20.

    Article  CAS  Google Scholar 

  6. Fujisaki J, Omae M, Shimizu T, et al. Endoscopic findings of superficial Barrett’s esophageal adenocarcinoma–picking up the lesion at the early stage. Stomach Intesitne. 2016;51(10):1229–310.

    Google Scholar 

  7. Kuribayashi S, Kawada A, Hosaka H, et al. Endoscopic diagnosis and treatment of Barrett’s esophagus or Barrett’s adenocarcinoma. J Gastroenterol. 2015;57(1):3–14.

    Google Scholar 

  8. Dunbar KB, Spechler SJ. The risk of lymph-node metastasis in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gatroenterol. 2012;107(6):850–62.

    Article  Google Scholar 

  9. Ishihara R, Oyama T, Seiichiro A, et al. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52(7):800–8.

    Article  Google Scholar 

  10. The Japan Esophageal Society. Guidelines for diagnosis and treatment of carcinoma of the esophagus. 2017.

    Google Scholar 

  11. Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2013;63:7–42.

    Article  Google Scholar 

  12. Pech O, May A, Manner H, et al. Long term outcome of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146:652–60.

    Article  Google Scholar 

  13. Yoshinaga S, Oda I, Tanaka Y, et al. Endoscopic diagnosis of superficial Barrett’s esophageal cancers—depth diagnosis (in Japanese abstract in English). Stomach Intestine. 2016;51:1311–20.

    Google Scholar 

  14. Arima M, Tada M, Tanaka Y, et al. Endoscopic ultrasonography in the diagnosis of Barrett’s esophageal cancer. Stomach Intestine. 2011;46:1852–60.

    Google Scholar 

  15. Oda I, Kusano M, Abe S, et al. Endoscopic diagnosis of tumor depth of adenocarcinoma at the esophagogastric junction. Stomach Intestine. 2009;44:1155–62.

    Google Scholar 

  16. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part 1. Esophagus. 2017;14:1–36.

    Article  Google Scholar 

  17. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.

    Article  Google Scholar 

  18. Akazawa N, Fujisaki J. Lymph node metastasis risk in superficial esophagogastric junction adenocarcinoma. Digestive Disease Week 2019, San Diego, CA, USA, May 2019.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Junko Fujisaki .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Suzuki, K., Akazawa, N., Fujisaki, J. (2020). Esophageal Cancer: Barrett’s Esophageal Adenocarcinoma (BEA). In: Fujisaki, J. (eds) Endoscopic Treatment Strategy for Upper GI Tract Neoplasms. Springer, Singapore. https://doi.org/10.1007/978-981-32-9737-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-32-9737-1_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-32-9736-4

  • Online ISBN: 978-981-32-9737-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics